 |
Benefits: /
Your news release is automatically posted to your site once it hits the wire.Saves you the time and cost of getting the news posted by a webmaster.Automatically emails releases to your databases.
Product Description
Choose automatic or manual mode. Automatic extraction of news from the wire, uploaded to your site. Tied in with the email database to automatically send the release to your list(s).
2010 News Releases December 23, 2010
Oncolytics Biotech® Inc. Accelerates Warrant Expiry Date
|
December 1, 2010
Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Ovarian Cancer Study
|
November 29, 2010
Oncolytics Biotech® Inc. Announces Publication of Phase I Clinical Trial Results Examining Combination of REOLYSIN® and Docetaxel in Clinical Cancer Research
|
November 18, 2010
Oncolytics Biotech® Inc. Announces Phase I Study in Pediatric Patients with Relapsed or Refractory Solid Tumors to be Conducted by the Children's Oncology Group and Sponsored by the National Cancer Institute
|
November 10, 2010
Oncolytics Biotech® Inc. Announces Third Quarter 2010 Results
|
November 8, 2010
Oncolytics Biotech® Inc. Closes Cdn$28.77 Million Bought Deal Financing
|
November 1, 2010
Oncolytics Biotech® Inc. Collaborators to Present Reovirus Research at the EORTC-NCI-AACR Meeting
|
October 28, 2010
Oncolytics Biotech® Inc. Announces Cdn$25 Million Bought Deal Financing
|
October 26, 2010
Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the International Symposium on CTL and Immunostimulation
|
October 4, 2010
Oncolytics Biotech® Inc. to Present at BIO Investor Forum
|
| Page 1 Of 4 |
| Next |
|
|
|
|
|
|
You are viewing our Quote and Chart Demo using ticker symbol T.ONC
|
|
F 888.329.6696